Company intelligence / Profile preview
CZ BioMed Corp
Tampa, Florida, United Statesczbiomed.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Developing RVLYSIS, a genetically engineered oncolytic RSV that selectively kills tumor cells; one reported case of a stage 4 colon cancer patient receiving 48 doses and becoming cancer-free, but lacks formal clinical data
- Therapeutic areas
- Oncology
- Modalities
- Oncolytic virus therapy
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Asan Medical Center (via Well Marker Bio Co. Ltd.)Kocal Consulting CorporationUniversity of Texas Health Science Center at San Antonio (patent license)
Beyond the preview
Go deeper on CZ BioMed Corp.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CZ BioMed Corp.